ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

Clinical trial NCT02836457 · COMPLETED

Trial details

NCT number: NCT02836457
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Venous Thromboembolism

Start date: 2016-07-01
Primary completion: 2018-07-31
Enrollment: 1134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.